Environmental Issue Committee

Basic Policy

As a pharmaceutical industry involved in life and health, JPMA gathers opinions on various issues related to global environmental protection and examines measures to address them.

Priority Issues

Priority Tasks to be addressed

1. Carbon Neutral Action Plan Group

Each company is considering the emission of greenhouse gases in its corporate activities, either directly (Scope 1) or indirectly (Scope 2). In FY2024, JPMA will start sharing information among members and gathering the latest information by inviting experts. In FY2025, we applied for and were selected for a publicly solicited project by the Ministry of the Environment to further promote decarbonization efforts throughout the supply chain. The 13 companies that were selected to participate in the project spent eight months working together to create guidelines for Scope 3 calculations, rules for obtaining primary data, and engagement policies common to the pharmaceutical industry, with the support of Deloitte Tohmatsu, S.P.R. Blue Dot Green, and the Sustainable Management Promotion Organization (SMPO), which were commissioned by the Ministry of the Environment. In FY2026, the JPMA member companies will widely deploy the guidelines and promote reduction throughout the value chain by deepening collaboration and co-creation with suppliers and other industry organizations through the development of explanatory materials and other communication tools and the implementation of webinars. In addition, we will promote reductions throughout the value chain. In addition, with regard to the common Scope 1 issue of converting vehicles to EVs, the sharing of know-how and the exchange of information on the possibility of charging infrastructure sharing within the industry and cooperation with hospitals and pharmacies will be promoted in earnest.

2. Voluntary Action Plan Group for Establishing a Recycling-Oriented Society

Based on the results of the follow-up survey conducted by the Japan Federation of Pharmaceutical Manufacturers' Associations (JFPMA) in FY2025, we will continue to promote activities of member companies by sharing information on their initiatives to achieve the JFPMA's numerical targets for voluntary actions to create a recycling-based society and the targets of each member company. In particular, activities such as sharing of individual efforts will be undertaken with the aim of increasing the recycling rate of not only waste plastics but also thermal recovery (heat recovery) and conversion to material recycling. In addition, with the aim of improving the recycling rate of waste materials specific to the pharmaceutical industry (PTP sheets, etc.), the committee will hold meetings to exchange opinions with waste disposal trade associations, and begin gathering information on the development of applications for recycled products in cooperation with universities and NPOs.

3. Planning Group

Plan and conduct facility tours of companies that are engaged in environmental measures, not limited to pharmaceutical companies. In addition, lectures will be held to share the latest environmental technologies, policies, and best practices that will serve as reference for member companies' initiatives and cross-industry collaboration; continue to support JCIA's "Environmental Supply Chain Awards" project, which was launched in FY2025, to recognize companies and business partners that have made outstanding efforts; and By recognizing companies and business partners that have made outstanding efforts, we will motivate them and encourage them to set an example for other companies to follow. At the same time, the group will begin to study possible incentives and support measures to promote environmentally friendly activities.

TOP